Novo Nordisk A/S (NVO)

Novo Nordisk Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	44,151	26,464	15,655	14,392	12,653	10,720
Short-Term Investments	2,201	498	10,653	15,838	10,921	6,765
Cash & Short-Term Investments	46,352	26,962	26,308	30,230	23,574	17,485
Cash Growth	42.26%	2.49%	-12.97%	28.23%	34.82%	37.06%
Accounts Receivable	95,118	70,856	71,949	64,770	50,560	40,643
Other Receivables	15,488	18,330	16,356	10,491	6,945	6,156
Receivables	110,606	89,186	88,305	75,261	57,505	46,799
Inventory	51,205	49,623	40,849	31,811	24,388	19,621
Other Current Assets	2,605	6,682	6,326	2,344	2,727	1,690
Total Current Assets	210,768	172,453	161,788	139,646	108,194	85,595
Property, Plant & Equipment	240,787	208,378	161,680	90,961	66,671	55,362
Long-Term Investments	2,501	2,507	2,677	1,663	1,343	1,441
Goodwill	19,422	19,845	20,017	4,464	4,615	4,346
Other Intangible Assets	92,351	110,208	90,804	55,942	46,324	38,825
Long-Term Deferred Tax Assets	26,881	23,647	24,648	20,380	13,904	8,672
Other Long-Term Assets	6,450	5,864	4,016	1,430	206	267
Total Assets	599,160	542,902	465,630	314,486	241,257	194,508

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15,217	19,758	17,140	25,606	15,587	8,870
Accrued Expenses	-	917	960	600	875	-
Short-Term Debt	-	928	5,792	456	480	12,862
Current Portion of Long-Term Debt	16,738	9,753	5,983	4,848	-	-
Current Portion of Leases	-	1,336	1,338	1,174	986	822
Current Income Taxes Payable	27,586	8,416	9,716	7,116	7,091	3,658
Other Current Liabilities	189,909	174,553	176,685	129,855	95,921	73,304
Total Current Liabilities	249,450	215,661	217,614	169,655	120,940	99,516
Long-Term Debt	109,339	111,705	84,246	15,976	20,775	9,654
Long-Term Leases	8,403	7,236	5,428	4,552	3,543	3,307
Pension & Post-Retirement Benefits	665	861	903	742	762	1,280
Long-Term Deferred Tax Liabilities	3,583	6,611	5,515	10,162	7,061	5,271
Other Long-Term Liabilities	9,918	6,781	8,438	6,838	4,690	4,734
Total Liabilities	381,358	348,855	322,144	207,925	157,771	123,762

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	446	446	446	451	456	462
Retained Earnings	220,552	195,298	144,448	104,839	80,587	72,004
Treasury Stock	-6	-2	-2	-5	-6	-6
Comprehensive Income & Other	-3,190	-1,695	-1,406	1,276	2,449	-1,714
Shareholders' Equity	217,802	194,047	143,486	106,561	83,486	70,746
Total Liabilities & Equity	599,160	542,902	465,630	314,486	241,257	194,508

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	134,480	130,958	102,787	27,006	25,784	26,645
Net Cash (Debt)	-88,128	-103,996	-76,479	3,224	-2,210	-9,160
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-19.85	-23.38	-17.14	0.72	-0.49	-1.99
Filing Date Shares Outstanding	4,409	4,444	4,441	4,458	4,501	4,558
Total Common Shares Outstanding	4,409	4,444	4,441	4,458	4,501	4,558
Working Capital	-38,682	-43,208	-55,826	-30,009	-12,746	-13,921
Book Value Per Share	49.40	43.66	32.31	23.90	18.55	15.52
Tangible Book Value	106,029	63,994	32,665	46,155	32,547	27,575
Tangible Book Value Per Share	24.05	14.40	7.36	10.35	7.23	6.05
Land	-	65,559	61,374	48,990	43,403	41,076
Machinery	-	71,133	67,205	49,930	45,662	43,720
Construction In Progress	-	130,622	85,497	39,663	22,361	11,091

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error